Gapping up
In reaction to strong earnings/guidance: PSUN +9%, OXGN +2.5%, ADBE +0.8%, KBH +0.8%, ALOT +0.6%.
M&A news: HZNP +19.6% (to acquire Vidara Therapeutics; accelerated transformation of Horizon to a profitable specialty pharma company ),YHOO +0.9% ( Bloomberg discusses that YHOO may make larger acquisitions following Alibaba).
Select EU financial related names showing strength: DB 2.7%, NBG 1.8%, BCS 1.7%.
Select 3D Printing stocks trading higher: DDD +1.2%, XONE +1.0%.
Other news: PRTA +8.5% (announced clinical data to be presented at International Symposium on Amyloidosis), WPCS +7.2% (announced that the beta version of the BTX trader platform), EXAS +7.1% (results of a clinical trial of Cologuard show unprecedented rates of precancer and cancer detection by a noninvasive test), CWH +3.5% (Corvex Management and Related Fund Management announce that holders of over 81% of outstanding shares approve removal of entire Board of Trustees), PLUG +3.5% (cont vol), CERE +3.3% (still checking), NSPH +2.2% (entered into $30 mln common stock purchase agreement with Aspire Capital), VRNS +2.2% (still checking), THRX +2.1% (disclosed it was informed by its partner, Clinigen, that the European Commission has lifted the Europe-wide suspension of Marketing Authorization and amended the Marketing Authorization for VIBATIV), WLT +2% (commences private offerings of $100 mln aggregate principal amount of 9.500% senior secured notes due 2019 and $350 mln aggregate principal amount of senior secured second lien PIK toggle notes due 2020), FCEL +1.8% (continued vol), OPTT +1.7% (still checking).
Analyst comments: CGEN +4.5% (initiated with a Buy at Jefferies), JNPR +3.3% (upgraded to Outperform from Market Perform at Wells Fargo), TEVA +1.4% (upgraded to Neutral from Sell at Goldman), SU +1.1% (initiated with a Sector Outperform at CIBC Wrld Mkts), RIG +1% (upgraded to Neutral from Sell at Citigroup), EPD +0.9% (upgraded to Outperform from Neutral at Credit Suisse)